PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.34%
Revenue growth under 50% of AVGO's 17.91%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
7.29%
Gross profit growth under 50% of AVGO's 26.24%. Michael Burry would be concerned about a severe competitive disadvantage.
14.75%
Positive EBIT growth while AVGO is negative. John Neff might see a substantial edge in operational management.
14.68%
Positive operating income growth while AVGO is negative. John Neff might view this as a competitive edge in operations.
21.75%
Positive net income growth while AVGO is negative. John Neff might see a big relative performance advantage.
23.26%
Positive EPS growth while AVGO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
23.81%
Positive diluted EPS growth while AVGO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-1.04%
Share reduction while AVGO is at 10.80%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.63%
Reduced diluted shares while AVGO is at 11.93%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
9.10%
Dividend growth of 9.10% while AVGO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
20.02%
OCF growth under 50% of AVGO's 48.39%. Michael Burry might suspect questionable revenue recognition or rising costs.
-7.07%
Negative FCF growth while AVGO is at 31.58%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
54.53%
Positive 10Y revenue/share CAGR while AVGO is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
32.29%
Positive 5Y CAGR while AVGO is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
2.56%
Positive 3Y CAGR while AVGO is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
42.74%
Positive long-term OCF/share growth while AVGO is negative. John Neff would see a structural advantage in sustained cash generation.
6.47%
Positive OCF/share growth while AVGO is negative. John Neff might see a comparative advantage in operational cash viability.
40.02%
Positive 3Y OCF/share CAGR while AVGO is negative. John Neff might see a big short-term edge in operational efficiency.
99.29%
Positive 10Y CAGR while AVGO is negative. John Neff might see a substantial advantage in bottom-line trajectory.
85.55%
Positive 5Y CAGR while AVGO is negative. John Neff might view this as a strong mid-term relative advantage.
15.90%
Positive short-term CAGR while AVGO is negative. John Neff would see a clear advantage in near-term profit trajectory.
45.75%
10Y equity/share CAGR above 1.5x AVGO's 20.90%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
3.31%
Below 50% of AVGO's 20.90%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
1.15%
Below 50% of AVGO's 20.90%. Michael Burry suspects a serious short-term disadvantage in building book value.
508.03%
Dividend/share CAGR of 508.03% while AVGO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
370.06%
Dividend/share CAGR of 370.06% while AVGO is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
203.64%
3Y dividend/share CAGR of 203.64% while AVGO is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-11.01%
Firm’s AR is declining while AVGO shows 4.49%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
7.71%
Inventory growth well above AVGO's 5.88%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.81%
Asset growth well under 50% of AVGO's 10.99%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
4.09%
Under 50% of AVGO's 23.83%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
-3.80%
Our R&D shrinks while AVGO invests at 10.17%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
2.35%
SG&A declining or stable vs. AVGO's 17.50%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.